 Immunological studies interferon therapy chronic HBV infection identification factors response Lymphoblastoid interferon effective therapy patients chronic hepatitis virus infection immunological parameters predictive response therapy human leukocyte antigen type ratio natural killer cell activity IgM anti-HBc antibody levels A-induced lymphocyte proliferative response patients treatment addition mechanisms action interferon hepatitis virus clearance ratios natural killer activity lymphocyte proliferative response wk treatment beneficial response therapy sustained clearance HBeAg serum hepatitis virus DNA yr therapy IgM anti-HBc levels beneficial response therapy correlation response pretreatment ratio natural killer activity lymphocyte proliferative response human leukocyte antigen patients No measurable changes immunological parameters nonresponder group significant rise ratio fall peripheral number decline measurable NK activity responder group changes maximal time hepatitis virus DNA clearance transient increase hepatic inflammation